| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) USD | RVI BIOTECNOLOGÍA | 38,85% | 22,98% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (YDIS) EUR | RVI BIOTECNOLOGÍA | 38,64% | 22,00% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS C (ACC) USD | RVI BIOTECNOLOGÍA | 38,13% | 20,98% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) EUR | RVI BIOTECNOLOGÍA | 40,03% | 25,61% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) USD | RVI BIOTECNOLOGÍA | 40,12% | 26,56% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) EUR | RVI BIOTECNOLOGÍA | 37,66% | 19,56% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) USD | RVI BIOTECNOLOGÍA | 37,97% | 20,60% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS W (ACC) USD | RVI BIOTECNOLOGÍA | 40,02% | 26,47% | · | · |
| FRANKLIN GLOBALAMENTAL STRATEGIES W (ACC) EUR | MIXTO FLEXIBLE | 10,77% | 33,40% | 28,31% | · |
| FRANKLIN GLOBALAMENTAL STRATEGIES W (ACC) EUR-H1 | MIXTO FLEXIBLE | 8,13% | 35,65% | 11,21% | · |
